Dr Reddy's Laboratories has announced that its chemical manufacturing facility at Cuernavaca, Mexico, has received a four-item warning letter from the United States Food and Drug Authority (USFDA).

The USFDA inspected Dr Reddy's Mexico facility in November 2010. That inspection resulted in issuance of form FDA 483 with observations. Dr Reddy's said that it responded to the 483 observation by implementing a number of corrective actions.